Is Eotaxin‐1 a serum and urinary biomarker for prostate cancer detection and recurrence?

E-ISSN： 1097-0045|75|16|1904-1909

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.16, 2015-12, pp. : 1904-1909

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Usefulness of the Nadir Value of Serum Prostate-Specific Antigen Measured by an Ultrasensitive Assay as a Predictor of Biochemical Recurrence after Radical Prostatectomy for Clinically Localized Prostate Cancer

Urologia Internationalis, Vol. 76, Iss. 3, 2006-04 ,pp. : 227-231

Karger

Access to resources Recommend Favorite

Urinary biomarkers for the detection of prostate cancer in patients with high‐grade prostatic intraepithelial neoplasia

THE PROSTATE, Vol. 75, Iss. 10, 2015-07 ,pp. : 1102-1113

John Wiley & Sons Inc

Access to resources Recommend Favorite

Baseline and longitudinal plasma caveolin‐1 level as a biomarker in active surveillance for early‐stage prostate cancer

BJU INTERNATIONAL, Vol. 121, Iss. 1, 2018-01 ,pp. : 69-76

John Wiley & Sons Inc

Access to resources Recommend Favorite

EN2: a novel prostate cancer biomarker

By McGrath Sophie E Michael Agnieszka Morgan Richard Pandha Hardev

Biomarkers in Medicine, Vol. 7, Iss. 6, 2013-12 ,pp. : 893-901

Future Medicine

Access to resources Recommend Favorite

ERG protein expression as a biomarker of prostate cancer

By Falzarano Sara Moscovita Magi-Galluzzi Cristina

Biomarkers in Medicine, Vol. 7, Iss. 6, 2013-12 ,pp. : 851-865

Future Medicine

Access to resources Recommend Favorite